Chris Hutchison

Chris Hutchison is the current President & CEO at AccuVein. Prior to their current position, Chris served as the President and CEO of Cheetah Medical from March 2013 to November 2019. While at Cheetah Medical, they were responsible for leading the company as the global leader in non-invasive hemodynamic monitoring. In October 2019, Cheetah Medical was acquired by Baxter.

From January 2006 to February 2013, Chris served as the V.P. & General Manager Vascular Therapies International at Covidien. In this role, they were responsible for Covidien's Vascular Therapy business outside of the United States. Chris managed sales and marketing operations with direct employees in Europe, South America and Asia.

Prior to their time at Covidien, Chris served as the President of Smiths Critical Care at Smiths Medical from August 2003 to October 2005. Before their time at Smiths Medical, Chris worked at B.Braun from January 1984 to December 1996 in various roles.

Chris Hutchison has a Bachelor's degree in Management from the University of Minnesota.

Some individuals on their team include Jeff Schou - VP, International Business Development, Kevin McArdle - CFO, and Philip Spiegel - Chief Sales Officer.